Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning.
Aberrant methylation of CpG islands in gene promoters often represents an early clonal event in carcinogenesis. Accordingly, defining methylation profiles may be useful for developing marker panels for early detection or predicting the risk of cancer precursors. To identify specific genes frequently methylated in cervical cancer, we conducted methylation profiling of 20 primary human cervical cancers using NotI-based restriction landmark genomic scanning (RLGS). Of 2,172 RLGS fragments analyzed (average, 1,753 CpG islands per patient), 186 RLGS fragments were lost in at least one tumor and 40 were lost in three or more. Methylation was identified in 19 (95%) of 20 tumor samples compared with normal DNA. Bisulfite sequencing was conducted to confirm RLGS results. Of the confirmed markers frequently methylated, we developed Methylight assays for two corresponding genes, nucleolar protein 4 (NOL4), and lipoma HMGIC fusion partner-like protein 4 (LHFPL4), which were methylated in 85% and 55% of cancers, respectively. Using these assays, we further confirmed frequent CpG island methylation in the original cancers and in another independent series of 15 cervical cancers. We also showed methylation at a reduced frequency in a set of carefully reviewed cytology specimens demonstrating cells exfoliated from cancer precursor lesions. In summary, we identified, for the first time, NOL4 and LHFPL4 as novel methylation targets specific for cervical cancer. Inclusion of NOL4 and LHFPL4 in evaluating methylation panels for early detection, risk prediction, and etiologic research on cervical cancer is warranted.
Wang
Sophia S
SS
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852-7234, USA. wangso@mail.nih.gov
Smiraglia
Dominic J
DJ
Wu
Yue-Zhong
YZ
Ghosh
Srimoyee
S
Rader
Janet S
JS
Cho
Kathleen R
KR
Bonfiglio
Thomas A
TA
Nayar
Ritu
R
Plass
Christoph
C
Sherman
Mark E
ME
D002294:Carcinoma, Squamous Cell / Q000235:genetics*; D018899:CpG Islands; D019175:DNA Methylation; D005260:Female; D015894:Genome, Human; D006801:Humans; D002583:Uterine Cervical Neoplasms / Q000235:genetics*